Vol 5, No 6 (December 18, 2016): Translational Andrology and Urology (Testosterone Replacement Therapy)

Preface

Testosterone replacement therapy

Daniel A. Shoskes, Lawrence S. Hakim

PDF Pages: 812-813 Full Text (2197) Open Access

Original Article

A case series of the safety and efficacy of testosterone replacement therapy in renal failure and kidney transplant patients

Ahmad Majzoub, Daniel A. Shoskes

PDF Pages: 814-818 Full Text (6680) Open Access

Improvement of endothelial function following initiation of testosterone replacement therapy

Daniel A. Shoskes, Barbara Tucky, Allan S. Polackwich

PDF Pages: 819-823 Full Text (2800) Open Access

Review Article

Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy

Andrew J. Davidiuk, Gregory A. Broderick

PDF Pages: 824-833 Full Text (5584) Open Access

Pharmacology of testosterone replacement therapy preparations

Jennifer J. Shoskes, Meghan K. Wilson, Michael L. Spinner

PDF Pages: 834-843 Full Text (17013) Open Access

Off label therapies for testosterone replacement

Lorenzo DiGiorgio, Hossein Sadeghi-Nejad

PDF Pages: 844-849 Full Text (11066) Open Access

Testosterone replacement therapy: role of pituitary and thyroid in diagnosis and treatment

Megan Crawford, Laurence Kennedy

PDF Pages: 850-858 Full Text (84615) Open Access

Testosterone replacement in the infertile man

Ahmad Majzoub, Edmund Sabanegh Jr

PDF Pages: 859-865 Full Text (7280) Open Access

Effects of varicocelectomy on serum testosterone

Patrick Whelan, Laurence Levine

PDF Pages: 866-876 Full Text (10084) Open Access

Hormone therapy for transgender patients

Cécile A. Unger

PDF Pages: 877-884 Full Text (31487) Open Access

Hypogonadism and testosterone replacement therapy in end-stage renal disease (ESRD) and transplant patients

Grace Snyder, Daniel A. Shoskes

PDF Pages: 885-889 Full Text (7665) Open Access

Testosterone replacement therapy and voiding dysfunction

Wesley Baas, Tobias S. Köhler

PDF Pages: 890-897 Full Text (37894) Open Access

Testosterone replacement therapy and the heart: friend, foe or bystander?

David S. Lopez, Steven Canfield, Run Wang

PDF Pages: 898-908 Full Text (3656) Open Access

Testosterone therapy and prostate cancer

Alexander W. Pastuszak, Katherine M. Rodriguez, Taylor M. Nguyen, Mohit Khera

PDF Pages: 909-920 Full Text (8509) Open Access

Opinion

Impact of recent FDA ruling on testosterone replacement therapy (TRT)

Sarita O. Metzger, Arthur L. Burnett

PDF Pages: 921-926 Full Text (12848) Open Access

Mini-Review

Testicular compartment syndrome: an overview of pathophysiology, etiology, evaluation, and management

Jason Gandhi, Gautam Dagur, Yefim R. Sheynkin, Noel L. Smith, Sardar Ali Khan

PDF Pages: 927-934 Full Text (7720) Open Access

Guideline

Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios

Ashok Agarwal, Ahmad Majzoub, Sandro C. Esteves, Edmund Ko, Ranjith Ramasamy, Armand Zini

PDF Pages: 935-950 Full Text (19619) Open Access

Commentary

Intralesional collagenase clostridium histolyticum study provides real-world analysis

Nora M. Haney, Kenneth J. DeLay, Wayne J. G. Hellstrom

PDF Pages: 951-952 Full Text (1657) Open Access

Belatacept in renal transplantation—quo vadis?

Timm H. Westhoff

PDF Pages: 953-955 Full Text (2254) Open Access

Commentary to low-energy shock wave therapy ameliorates erectile dysfunction in a pelvic neurovascular injuries rat model, published in J Sex Med 2016;13:22-32 by Li H, Matheu P, Sun F, et al.

Javier C. Angulo

PDF Pages: 956-957 Full Text (1937) Open Access

Invited commentary on GETUG-AFU 16

W. Robert Lee W. Robert Lee

PDF Pages: 958-960 Full Text (2695) Open Access

Friend or foe: role of E-cadherin in prostate cancer metastasis

Ching-Yu Lin, Chih-Pin Chuu

PDF Pages: 961-963 Full Text (2453) Open Access

Editorial

The luminal-basal paradigm in the urothelial cancer: hope for individualized approach

Leonardo Oliveira Reis

PDF Pages: 964-965 Full Text (2006) Open Access

Prostate cancer and hypofractionation: really a new standard of care?

Christian Carrie, Ronan Tanguy

PDF Pages: 966-967 Full Text (1818) Open Access

Radium-223 and concomitant therapies: prospects and prudence

Oladapo Yeku, Susan F. Slovin

PDF Pages: 968-970 Full Text (2764) Open Access

A randomised control trial of salvage radiotherapy and androgen deprivation therapy following prostatectomy: commentary on five year follow-up findings

Scott Williams, John W. Yaxley, Geoffrey D. Coughlin, Robert A. Gardiner

PDF Pages: 971-973 Full Text (2131) Open Access

Cabozantinib in advanced renal cell carcinoma: a METEOR impact on clinical practice

Paolo Grassi, Elena Verzoni, Alessia Mennitto, Giuseppe Procopio

PDF Pages: 974-976 Full Text (2184) Open Access

Low-energy shock wave therapy ameliorates erectile dysfunction in a pelvic neurovascular injuries rat model

Delphine Behr-Roussel, François Giuliano

PDF Pages: 977-979 Full Text (4351) Open Access

Liquid biopsies in bladder cancer—did we find the Holy Grail for biomarker analyses?

Michael Rink, Shahrokh F. Shariat, Armin Soave

PDF Pages: 980-983 Full Text (2843) Open Access

Correspondence

The panoramic view of clear cell renal cell carcinoma metabolism: values of integrated global cancer metabolomics

James J. Hsieh, Emily H. Cheng

PDF Pages: 984-986 Full Text (2310) Open Access

Disclosure:

The focused issue “Testosterone Replacement Therapy” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Daniel A. Shoskes and Lawrence S. Hakim served as the unpaid Guest Editors for the focused issue.